Daiichi Sankyo SWOT Analysis
Here is a detailed SWOT analysis of Daiichi Sankyo covering strengths, weaknesses, opportunities and threats.
Daiichi Sankyo Strengths
- Has a strong workforce of over 30,000 employees
- Leading producer of Benicar which is angiotensin II receptor antagonist
- It is one of the largest pharmaceutical company in Japan
- Strong presence in US, Europe, India, China, Brazil, Thailand and some others
- Strong brand establishment through many major acquisitions
Above are the strengths in the SWOT Analysis of Daiichi Sankyo. The strengths of Daiichi Sankyo looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Daiichi Sankyo Weaknesses
- Despite being a strong brand, had a limited market share due to international competitors
- Operates in limited segments such as Oncology & Cardiovascular segment
These were the weaknesses in the Daiichi Sankyo SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Daiichi Sankyo Opportunities
- Increasing world population and more awareness about health
- More people suffering from chronic diseases such as cancer, cardiovascular diseases
- Increasing awareness of healthcare solutions
Above we covered the opportunities in Daiichi Sankyo SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Daiichi Sankyo Threats
- Natural disasters in Japan
- increasing stringency in drug development guidelines
- Global economic slowdown
The threats in the SWOT Analysis of Daiichi Sankyo are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Daiichi Sankyo SWOT analysis.
Read Similar SWOT analysis
About Daiichi Sankyo
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Daiichi Sankyo Overview | |
|---|---|
| Parent Company |
Daiichi Sankyo |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Passion for innovation, Compassion for patients |
| USP |
It is one of the largest pharmaceutical company in Japan |
| Daiichi Sankyo STP | |
| Segmentation |
Oncology & Cardiovascular diseases |
| Target Group |
Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease |
| Positioning |
They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time |
Browse marketing analysis of more brands and companies similar to Daiichi Sankyo. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
